Physician profile
Dean E Burget, JR.
NPI 1164402475
$1,236.32
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,167 · 2020: $69.25.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Pharmaceuticals, INC. | $526.08 | 2019 | |
| Sun Pharmaceutical Industries INC. | $181.53 | 2019 | |
| Janssen Biotech, INC. | $88.37 | 2019 | |
| Ucb, INC. | $79.01 | 2019-2020 | |
| Abbvie INC. | $67.03 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $49.83 | 2019 | |
| Promius Pharma LLC | $28.19 | 2019 | |
| Lilly USA, LLC | $27.74 | 2019 | |
| Dusa Pharmaceuticals, INC. | $27.56 | 2019 | |
| Sandoz INC. | $24.25 | 2019 | |
| Helsinn Therapeutics (U.S.), INC. | $23.15 | 2019 | |
| Epi Health, LLC | $21.71 | 2019 | |
| Genentech USA, INC. | $18.99 | 2020 | |
| Encore Dermatology INC. | $18.10 | 2019 | |
| Dermira, INC. | $14.23 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almirall LLC | $14.00 | 2019 | |
| Celgene Corporation | $13.44 | 2019 | |
| Amgen INC. | $13.11 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dean Burget listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.